There is no Press for this Ticker
Sector: Health Care.Industry: Biotechnology
Celyad Oncology is a biopharmaceutical company, specialized in cell therapy. It develops technologies and treatments to treat severe diseases with poor prognosis. The company focuses on Immuno oncology, Cardiology, and Medical devices. Its main product candidates include CAR-T and C-Cure. The firm has CYAD-01 and CYAD-02 programs in pipeline. The company owns trademarks and service marks including CELYAD, C-CATH, C_CURE, CATH and C-CATHez and CARDIO 3 BIOSCIENCES. The firm has Cardiology and Immuno-oncology operating segments.

Related Companies

TickerCompanyChg %Mkt Cap
CLYYFCelyad Oncology0%130M

Celyad Oncology Company Questions & Answers

Q

How do I buy Celyad Oncology (CLYYF) stock?

A

You can purchase shares of Celyad Oncology (OTC: CLYYF) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Celyad Oncology's (CLYYF) main competitors?

A

There are no as such competitors for Celyad Oncology.

Q

What is the target price for Celyad Oncology?

A

There is no analysis for Celyad Oncology

Q

How much is Celyad Oncology (CLYYF) stock ?

A

The stock price for Celyad Oncology (OTC: CLYYF) is $9.15 last updated Mon Oct 12 2020 17:25:50 GMT+0000 (Coordinated Universal Time).

Q

When is the next Celyad Oncology (CLYYF) dividend?

A

There are no upcoming dividends for Celyad Oncology.

Q

When is Celyad Oncology (OTC:CLYYF) reporting earnings?

A

There are no earnings for Celyad Oncology

Q

When is the upcoming split for CLYYF?

A

There is no upcoming split for Celyad Oncology.